A two-day conference that covers drug development strategies in the United States and Pacific Rim, including regulatory compliance issues facing Asian and American companies, the future of global drug discovery, and financing opportunities in Asia. Hundreds of pharmaceutical and biotech executives attend, along with industry consultants, CROs and regulatory officials. More information and online registration is here.